Why is Orchid Pharma falling/rising?

As of 03-Nov, Orchid Pharma Ltd's stock price is currently at Rs 770.10, reflecting an increase of Rs 44.2, or 6.09%. The stock has shown a positive performance today, outperforming its sector by 4.79% and achieving a consecutive gain over the last two days with an overall return of 8.59%. The stock reached an intraday high of Rs 800.6, indicating strong trading activity, although it has also experienced a wide trading range of Rs 80.6. Despite these short-term gains, the company faces significant long-term challenges, including a weak return on equity (ROE) of 4.68% and declining operating profits, which have fallen by 19.64%. Furthermore, the company has reported negative results for the last three consecutive quarters, contributing to a substantial year-to-date decline of 57.62% in stock value.
Broader market context shows that while Orchid Pharma has gained 8.09% over the past week, the benchmark Sensex has declined by 0.94%, indicating that the stock is performing well relative to the broader market in the short term. However, over the past year, Orchid Pharma has significantly underperformed the market, generating a return of -46.82% compared to the Sensex's 5.34%. This stark contrast highlights the stock's volatility and the challenges it faces, despite recent positive movements. The high institutional holdings at 20.6% suggest that more informed investors are backing the stock, yet the overall weak fundamentals and negative growth trends raise concerns about its sustainability in the long run.